Join
Live feed
·
INSIDERFilingvia Quantisnow
Trevi Therapeutics Inc. logo

Chief Scientific Officer Sciascia Thomas exercised 2,631 shares at a strike of $1.43 and sold $17,365 worth of shares (2,631 units at $6.60) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TRVI· Trevi Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TRVI (Trevi Therapeutics Inc.) and more on Quantisnow.